I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 9 studies | 33% ± 18% | |
| neuron | 8 studies | 32% ± 12% | |
| endothelial cell | 7 studies | 22% ± 6% | |
| oligodendrocyte precursor cell | 7 studies | 27% ± 9% | |
| interneuron | 6 studies | 29% ± 15% | |
| oligodendrocyte | 6 studies | 25% ± 5% | |
| fibroblast | 5 studies | 22% ± 4% | |
| GABAergic neuron | 5 studies | 36% ± 11% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 21% ± 5% | |
| ciliated cell | 4 studies | 29% ± 8% | |
| natural killer cell | 4 studies | 21% ± 3% | |
| regulatory T cell | 4 studies | 17% ± 3% | |
| connective tissue cell | 3 studies | 18% ± 3% | |
| neural crest cell | 3 studies | 17% ± 1% | |
| epithelial cell | 3 studies | 38% ± 5% | |
| myofibroblast cell | 3 studies | 21% ± 4% | |
| pericyte | 3 studies | 20% ± 3% | |
| smooth muscle cell | 3 studies | 18% ± 3% | |
| amacrine cell | 3 studies | 37% ± 7% | |
| Mueller cell | 3 studies | 21% ± 4% | |
| dendritic cell | 3 studies | 25% ± 7% | |
| plasmacytoid dendritic cell | 3 studies | 23% ± 4% | |
| astrocyte | 3 studies | 19% ± 3% |
